Article
Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: the case of hydroxychloroquine in COVID-19
2021-06-25
Abstract excerpt
In the early phases of the COVID-19 pandemic, drug repurposing was widely used to identify compounds that could improve the prognosis of symptomatic patients infected by SARS-CoV-2. Hydroxychloroquine (HCQ) was one of the first drugs used to treat COVID-19 patients due to its supposed capacity of inhibiting SARS-CoV-2 infection and replication in vitro . While its efficacy is debated, HCQ has been associated wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- adec2857-ae12-5afe-b7dd-3e9716640928
- DOI
- 10.1101/2021.06.25.449913
